Stay updated on CPX-351 and Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.3 to v3.5.4, indicating a minor platform release. No study content or page functionality changes are introduced by this update.
    Difference
    0.1%
    Check dated 2026-05-15T06:28:43.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry (version 20) was added to the Record History with a Study Status update dated 2026-04-21, and a subsequent 2026-04-24 entry records another Study Status change.
    Difference
    0.3%
    Check dated 2026-05-01T08:30:15.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s footer/test tooling label was updated from Revision v3.5.2 to v3.5.3, indicating a maintenance/version release rather than a change to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:26.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:15.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.0 (replacing v3.4.3). The overall record history content remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-19T04:52:52.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; Deleted Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:38:16.000Z thumbnail image

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.